Document is current

Any future updates will be listed below

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s13048-023-01216-z

Published Online: 2023-07-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark